Cielo Health publishes both rungs of its NAD+ ladder as monthly figures against a struck-through regular rate, and runs the whole site in English and Spanish. On the same page it sells a precursor at identical figures, which it labels correctly and which a careless read would record as a second NAD+ price.
What Cielo Health charges
NAD+: $115/mo — now starting at, per month on the 3 Month Plan; the same table publishes $149/Month on the Monthly Plan and strikes through "Regularly $199/month"
Cielo Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
Two rungs, a struck rate, and a month on each
The plan table publishes a three-month figure and a monthly figure, both with a month marker, and shows the undiscounted rate beside them.
Neither had to be derived from a prepaid total, so neither carries the division risk that shape usually does.
The card also states that the price is the same at any dose, on the same surface as the figure.
The table renders under a tab control, and the tab carrying the figures is the one that opens by default.
The product beside it is a different molecule
Directly under the NAD+ card, the page sells an injection of a precursor and prices it with the identical ladder.
The seller labels it a precursor in its own words and runs a short section explaining the difference between the two.
That labelling is why only one row is recorded here: a precursor is not the compound this site tracks.
Two identical ladders on one page, for two molecules, is exactly the arrangement that ends up double-counted by a sweep that reads figures rather than headings.
What is not published
No state list appears on any page read.
The pharmacy is described only as a set of regulated partners, a phrase that names nobody and describes an arrangement the agency it invokes does not actually confer.
No operating company under a corporate suffix appears on the pages read.
Lab work is not described as included in what is charged.
The host, and one broken path on it
Two nonsense paths were fired at this host in the same run as everything above and both returned 404 with a short error page.
The site's own FAQ path returns the same 404 at the same length, so the FAQ is reachable only from the home page.
That is worth knowing before concluding anything is unpublished here on the strength of a missing page.
The federal warning-letter record was screened by brand against the full table, with controls in the same run, and returned nothing.
Who it's for
Spanish-reading buyers who want the whole site, not just a landing page, in their language.
Readers who want both plan rungs published rather than only the lowest.
Buyers who want the same price at any dose stated on the card.
Shoppers who want the undiscounted rate shown beside the offer.
Who should look elsewhere
Readers who need the dispensing pharmacy named.
Buyers who want more than one tracked compound from one seller.
Anyone who needs a state footprint or an operating company.
Shoppers who would confuse a precursor for the compound itself, since both are sold here at the same figures.
Strengths
Publishes both rungs of its ladder with a month on each, and prints the undiscounted rate beside them
States that the price is the same at any dose, on the same card as the figure
Distinguishes NAD+ from its precursor in its own copy rather than selling them as one thing
Serves the whole site in English and Spanish from a language control in the header
Trade-offs
Sells one tracked compound, and its neighbouring product is a precursor at identical figures
Describes "Regulated FDA pharmacy partners" — a phrase that names nobody and misstates what the FDA does
Publishes no state list and no operating company
Its own /faqs path returns a 404, so the FAQ is only reachable from the home page
How we verified this
Rendered every page cited on this row in a real browser engine and read the laid-out text nodes, so nothing here rests on markup that never reaches a reader.
Fired two nonsense-path controls at this host in the same run — one at the root and one inside the section the priced pages live in — and compared the address requested with the address actually served.
Joined every text node before scanning for a dollar sign, so a figure split across nested elements could not read as an absence.
Screened this seller in the live federal warning-letter record by brand and, where an operating company is published, by entity — pulling the whole table and filtering locally, because that endpoint's own search parameter is silently ignored.
Ran a known-good positive control and a nonsense negative control against that table in the same run, and read the company column of every returned record rather than accepting a full-text match.
Read the heading above each price ladder before recording anything, and declined to record the precursor's identical ladder as a second price for the tracked compound.
Opened the second tab on each product card as well as the default one, and confirmed it carries no figure.
Checked the site's own FAQ path, which returns the same 404 as the nonsense controls, before treating anything as unpublished.
A provider to compare Cielo Health against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Yes. Both rungs are published as per-month figures, with the undiscounted monthly rate struck through beside them.
Why is only one product recorded?
The second product on the page is a precursor, which the seller labels as such. It is not the compound this site tracks, even though it carries identical figures.
Does it name the pharmacy?
No. It refers to regulated pharmacy partners and names none.
Which states does it serve?
No list is published on any page read.
Is the site available in Spanish?
Yes. A language control in the header switches the whole site, and the sitemap carries a separate Spanish index.
Cielo Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.